39 related articles for article (PubMed ID: 29341914)
1. Effects of the Glass-Forming Ability and Annealing Conditions on Cocrystallization Behaviors via Rapid Solvent Removal: A Case Study of Voriconazole.
Wong SN; Chan SWS; Peng X; Xuan B; Lee HW; Tong HHY; Chow SF
Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33327381
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Drug with Good Glass-Forming Ability Loaded Mesoporous Silica Nanoparticles and Its Impact Toward in vitro and in vivo Studies.
Budiman A; Anastasya G; Handini AL; Lestari IN; Subra L; Aulifa DL
Int J Nanomedicine; 2024; 19():2199-2225. PubMed ID: 38465205
[TBL] [Abstract][Full Text] [Related]
3. Predicting Glass-Forming Ability of Pharmaceutical Compounds by Using Machine Learning Technologies.
Jiang J; Ouyang D; Williams RO
AAPS PharmSciTech; 2023 Apr; 24(5):103. PubMed ID: 37072563
[TBL] [Abstract][Full Text] [Related]
4. Artificial Neural Networks to Predict the Apparent Degree of Supersaturation in Supersaturated Lipid-Based Formulations: A Pilot Study.
Bennett-Lenane H; O'Shea JP; Murray JD; Ilie AR; Holm R; Kuentz M; Griffin BT
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575483
[TBL] [Abstract][Full Text] [Related]
5. Impact of Laser Speed and Drug Particle Size on Selective Laser Sintering 3D Printing of Amorphous Solid Dispersions.
Thakkar R; Jara MO; Swinnea S; Pillai AR; Maniruzzaman M
Pharmaceutics; 2021 Jul; 13(8):. PubMed ID: 34452109
[TBL] [Abstract][Full Text] [Related]
6. Enabling formulations of aprepitant:
Palmelund H; Eriksen JB; Bauer-Brandl A; Rantanen J; Löbmann K
Int J Pharm X; 2021 Dec; 3():100083. PubMed ID: 34151250
[TBL] [Abstract][Full Text] [Related]
7. Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study.
Jara MO; Warnken ZN; Williams RO
Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33466598
[TBL] [Abstract][Full Text] [Related]
8. Use of Terahertz-Raman Spectroscopy to Determine Solubility of the Crystalline Active Pharmaceutical Ingredient in Polymeric Matrices during Hot Melt Extrusion.
Bordos E; Islam MT; Florence AJ; Halbert GW; Robertson J
Mol Pharm; 2019 Oct; 16(10):4361-4371. PubMed ID: 31436094
[TBL] [Abstract][Full Text] [Related]
9. Crystallization Tendency of Pharmaceutical Glasses: Relevance to Compound Properties, Impact of Formulation Process, and Implications for Design of Amorphous Solid Dispersions.
Kawakami K
Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31052392
[TBL] [Abstract][Full Text] [Related]
10. Effect of Polymer Hydrophobicity on the Stability of Amorphous Solid Dispersions and Supersaturated Solutions of a Hydrophobic Pharmaceutical.
Frank DS; Matzger AJ
Mol Pharm; 2019 Feb; 16(2):682-688. PubMed ID: 30645134
[TBL] [Abstract][Full Text] [Related]
11. Influence of preparation pathway on the glass forming ability.
Blaabjerg LI; Lindenberg E; Rades T; Grohganz H; Löbmann K
Int J Pharm; 2017 Apr; 521(1-2):232-238. PubMed ID: 28232267
[TBL] [Abstract][Full Text] [Related]
12. Computational predictions of glass-forming ability and crystallization tendency of drug molecules.
Alhalaweh A; Alzghoul A; Kaialy W; Mahlin D; Bergström CA
Mol Pharm; 2014 Sep; 11(9):3123-32. PubMed ID: 25014125
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues.
Bevernage J; Brouwers J; Brewster ME; Augustijns P
Int J Pharm; 2013 Aug; 453(1):25-35. PubMed ID: 23194883
[TBL] [Abstract][Full Text] [Related]
14. Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement.
Murdande SB; Pikal MJ; Shanker RM; Bogner RH
Pharm Dev Technol; 2011 Jun; 16(3):187-200. PubMed ID: 20429826
[TBL] [Abstract][Full Text] [Related]
15. Is there a correlation between the glass forming ability of a drug and its supersaturation propensity?
Blaabjerg LI; Lindenberg E; Löbmann K; Grohganz H; Rades T
Int J Pharm; 2018 Mar; 538(1-2):243-249. PubMed ID: 29341914
[TBL] [Abstract][Full Text] [Related]
16. The Influence of Polymers on the Supersaturation Potential of Poor and Good Glass Formers.
Blaabjerg LI; Grohganz H; Lindenberg E; Löbmann K; Müllertz A; Rades T
Pharmaceutics; 2018 Sep; 10(4):. PubMed ID: 30241425
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
